Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.

Vaxart Inc (VXRT) reports a remarkable revenue increase and strategic collaborations, despite facing challenges in vaccine trial timelines.

Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026 Published positive clinical results in the first quarter of 2026 demonstrating oral norovirus ...

A MAN who inflicted “atrocities” on another person has been jailed. Marc Blythin, 44, of Minffordd Street in Corris, near Machynlleth, was sentenced to four years and nine months' imprisonment at ...

After the United States government released its latest tranche of files on Jeffrey Epstein, Sri Lankan social media users claimed the documents revealed email conversations between Bill Gates and the ...

Sudan's 18-month cholera outbreak resulted in more than 100,000 cases nationwide, with an estimated 2,408 deaths.

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...

Covid-19 exposed tension in global preparedness, new global agreements need to reconcile global public good rhetoric with national interests.

According to Budiman, more than 125 countries have included the HPV vaccine in their national immunization programs. Research ...

While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and ...